A polymerase chain reaction (PCR)-based test was developed for the detection of Salmonella typhi in th,e blood specimens from patients with typhoid fever. Two pairs of oligonucleotide primers were designed to amplify a 343-bp fragment of the flagellin gene of S. typhi. Amplified products were analyzed by agarose gel electrophoresis and Southern blot hybridization by using a 32P-labeled 40-base probe internal to the amplified DNA. The nested PCR with two pairs of primers could detect 10 organisms of S. typhi as determined by serial dilutions of DNA from S. lyphi. The peripheral mononuclear cells from 11 of 12 patients with typhoid fever confirmed by blood culture were positive for DNA fragment of the flagellin gene of S. typhi, whereas 10 blood specimens of patients with other febrile diseases were negative. With the nested PCR, S. typhi DNAs were detected from blood specimens of four patients with suspected typhoid fever on the basis of clinical features but with negative cultures. We suggest that the PCR technique could be used as a novel diagnostic method of typhoid fever, particularly in culture-negative cases.
Typhoid fever caused by Salmonella typhi remains an important public health problem in many parts of the world. Rapid and sensitive laboratory methods for diagnosis of typhoid fever are essential for prompt and effective therapy. Although several serological assays for detecting S. typhi antigens or antibodies have been used for their rapidity and simplicity, no nonculture tests for typhoid fever have repeatedly been shown to be highly sensitive and specific (1) . The classical and the most commonly used serological method, the Widal test, is particularly unreliable with the single titers in endemic areas (8, 14) . Confirmation of typhoid fever requires the identification of S. typhi in clinical specimens. S. typhi can be isolated from more than 90% of patients with typhoid fever if blood, stool, rose spots, and bone marrow aspirates are all cultured (5) . If the culture of the mononuclear cell-platelet layer of blood is combined with cultures of bone marrow aspirate and rectal swab, the positive rate of detection can increase up to 100% (11) . Since it is often difficult to obtain bone marrow aspirates in many endemic areas, only blood specimens are cultured in most cases.
Blood culture, however, can detect only 45 to 70% of patients with typhoid fever, depending on the amount of blood sampled, the bacteremic level of S. typhi, the type of culture medium used, and the length of incubation period (6, 7) . In Korea, where typhoid fever is still common, diagnosis of many suspected cases on the basis of clinical findings cannot be confirmed because of negative cultures. The clinical usefulness of the culture method is further restricted because it takes at least 2 days until the identification of the organism. The development of a rapid and sensitive diagnostic method of typhoid fever, therefore, has a practical importance in endemic areas.
Previously, a DNA probe specific to the Vi antigen of S. typhi had been used to detect the organism in the blood of patients with typhoid fever (9, 10, 12) . This novel hybridization method, however, required concentration of bacteria * Corresponding author.
from the blood samples and amplification of total bacterial DNA by overnight incubation of the bacteria on nylon filters to increase the sensitivity of the probe. This process of concentration was inevitable, because patients with typhoid fever usually have less than 15 S. typhi cells per ml of blood, and the probe cannot detect fewer than 500 bacteria. The problem of sensitivity of DNA probes could be circumvented by polymerase chain reaction (PCR), which can detect very small amounts of DNA by enzymatic amplification. PCR with the sequences of Vi antigen is not feasible, because the nucleotide sequence of this antigen has not been fully investigated. We report here the development of a PCR-based assay which can detect S. typhi DNA by amplification of the flagellin gene of S. typhi in the blood of typhoid patients.
MATERUILS AND METHODS
Bacterial strains. Ten Salmonella strains, including two strains of S. typhi, seven non-Salmonella gram-negative organisms, Listeria monocytogenes, and Legionella pneumophila were studied for a test of specificity of the PCR (Table 1) . Nine Salmonella strains were obtained from the American Type Culture Collection (ATCC), and one S. typhi strain was isolated from a patient with typhoid fever admitted to the Asan Medical Center. All other organisms were blood-borne pathogens isolated at the Asan Medical Center, which were identified by the Automicrobic System (Vitek Inc., Hazelwood, Mo.). S. typhi ATCC 19430 was used as a positive reference.
Blood specimens. Blood specimens (3 ml) were obtained before antibiotic therapy from 12 patients with typhoid fever who were admitted to the Asan Medical Center consecutively during the period from December 1990 to March 1991. All cases were confirmed by blood culture. Blood specimens were also collected from 10 control patients with other febrile diseases which could mimic typhoid fever in terms of clinical manifestations. The diagnosis of these control patients were Escherichia coli bacteremia (2 patients), Kleb- 
G-3').
Preparation of DNA from bacteria and blood specimens for PCR. Chromosomal DNAs of Salmonella strains and other organisms were extracted as previously described (3) . After centrifugation at 3,000 x g of 0.5 ml of an overnight Luria broth culture, the resulting pellet was resuspended in 75 pl of 50 mM Tris-HCl buffer (pH 8.0) containing 0.9% glucose, 250 mM EDTA, and 140 p,g of lysozyme. The reactants were incubated at 37°C for 30 min. Next, 300 ,ul of 50 mM NaCl containing 1% sodium dodecyl sulfate (SDS) and 800 ,ug of proteinase K were added, and the incubation was continued for an additional 120 min. The procedure was followed by phenol-chloroform-isoamylalcohol (25:24:1) extraction. The DNA was precipitated by the addition of absolute ethanol and harvested by centrifugation. The mononuclear cells were obtained from whole blood specimens after density gradient centrifugation with Ficoll-Hypaque (Histopaque; Sigma Chemical Co., St. Louis, Mo.). The mononuclear cells were incubated with 1 mg of lysozyme at 37°C for 60 min and with 0.1% Triton X-100 and 2 mg of proteinase K Detection of PCR products. The DNA fragments of the flagellin gene of S. typhi amplified by the PCR were identified by two different methods. In the agarose gel electrophoresis, 10 ,ul of the amplified products from both rounds of the PCR was electrophoresed on a 1.5% agarose gel for 60 min at a constant 80 V, with TBE buffer (90 mM Tris-borate, 2 mM EDTA). Molecular size markers (1-kb DNA ladder, Bethesda Research Laboratories) were run concurrently. The gels stained with ethidium bromide were examined under UV illumination for the presence of a 458-or 343-bp band. In Southern blot hybridization, a 32P-labeled 40-base probe DNA located within the amplification product from the PCR was used. Capillary transfer of DNA from agarose gels to a GeneScreen Plus membrane (NEN, Boston, Mass.) was performed according to the manufacturer's instructions. Hybridization of oligonucleotide probe (3.0 x 108 cpm/4.g) was carried out in 6x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-5 x Denhardt's solution-0.5% SDS-100 ,ug of salmon sperm DNA per ml at 61°C for 16 h. After hybridization, membranes were washed in 6x SSC, 5 x SSC, and 4x SSC, consecutively, for 5 min each. The membranes were autoradiographed for 2 h by using X-Omat AR film (Eastman Kodak, Rochester, N.Y.) and intensifying screens at 80°C.
RESULTS
Specificity of the PCR. To verify that primers used in this study were specific for S. typhi, the nested PCR was carried out with DNAs from 10 Salmonella spp. and 9 other organisms. With the single round of PCR with ST 1 and ST 2, amplification products of the expected size (458 bp) were seen only from the extracts of two S. typhi strains but not from the extracts of other organisms both on the agarose gel electrophoresis and Southern blot hybridization (Fig. 1) . With the nested PCR, however, amplification products of 343 bp were detected from the extracts of two S. typhi strains and Salmonella muenchen but not from the extracts of other organisms when analyzed on an agarose gel (Fig. 1) 12 patients with typhoid fever. Amplification products from the nested PCR were analyzed by gel electrophoresis (A) and by Southern blot hybridization (B). Amplification products were seen in 11 of 12 specimens on the gel and autoradiograph after the nested PCR (lanes 5 and 7 to 16). No amplification products were seen with the single round of PCR (not shown). Lanes 2 to 4, negative controls (distilled water, leukocyte DNA, and DNA from blood of a patient with E. coli bacteremia, respectively); lanes 5 to 16, DNAs isolated from blood of typhoid patients; lane 17, positive control (S. typhi DNA, 65 fg); lanes 1 and 18, molecular weight markers (1-kb ladder). to 10 organisms) produced a visible amplification product of 343 bp on the gel (Fig. 2) . These results suggested that the nested PCR was necessary to detect the small numbers of organisms in the actual blood specimens which normally contain leukocyte DNA in excess amounts.
PCR with DNA from blood specimens of patients. With the first round of PCR on DNA from 12 blood specimens obtained from 12 patients with culture-confirmed typhoid fever before antibiotic therapy, no amplification products were seen on the gel. After the nested PCR, however, amplification products of 343 bp were seen in 11 of 12 specimens on the gel (Fig. 3) . Southern blot hybridization with a 32P-labeled internal probe showed the same pattern and confirmed the agarose gel results (Fig. 3) . A control experiment was carried out with DNAs from blood specimens of 10 control patients with other febrile diseases in the same manner as used for the nested PCR. No amplified products were observed on the gel and by Southern blot hybridization (data not shown). Finally, PCR was carried out on DNAs from blood of four patients with suspected typhoid fever on the basis of clinical features but without positive cultures. With the nested PCR, amplification products were seen in all four cases on the gel (Fig. 4) .
DISCUSSION
The flagellar antigen of S. typhi (Hl-d) is encoded by a 1,530-bp DNA sequence (4, 13) . Although flagellar antigen is not a structure specific to Salmonella species and d antigen is also present in many Salmonella species other than S. typhi (1, 2), the flagellin gene of S. typhi has unique nucleotide sequences in the hypervariable region of the gene (4) . The nucleotide sequences and predicted amino acid sequences of region VI (corresponding to nucleotide 969 to 1077) of the HJ-d flagellin gene of S. typhi are different from those of S. muenchen, which has also the HJ-d gene and Amplification products were seen in all four specimens on the gel and by Southern blot hybridization. Lanes 2 and 3, positive controls (65 fg of S. typhi DNA and DNA from blood of actual typhoid patient, respectively); lanes 4 to 6, negative controls (distilled water, leukocyte DNA, and DNA from blood of patient with E. coli bacteremia, respectively); lanes 7 to 10, DNA from blood of patients with suspected typhoid fever; lane 1, molecular weight marker (1-kb ladder).
nucleotide sequences highly homologous with S. typhi (4, 13) . These findings suggested that the PCR test, based on the unique sequence in the flagellin gene of S. typhi, could be used to detect S. typhi specifically in the clinical specimens. In our study, PCR with ST 1 and ST 2 was highly specific in detecting S. typhi DNA, whereas the nested PCR with ST 3 and ST 4 was rather nonspecific, detecting amplification products both of S. typhi and S. muenchen. This result could be anticipated because the nucleotide sequences of ST 3 and ST 4 were highly homologous between S. typhi and S. muenchen. In view of the practical use of PCR, however, this finding is thought to be not critical because PCR technique can be used to reinforce the clinical diagnosis of typhoid fever in patients with suspected clinical features of typhoid fever, such as high fever, leukopenia, hepatosplenomegaly, and so on, but with negative cultures. S. muenchen is an uncommon etiologic agent of gastroenteritis which can be clearly differentiated from typhoid fever on the basis of clinical findings. Furthermore, the detection of S. muenchen in blood specimen would be impossible with this PCR technique even if it is present, because it is subjected to be amplified by only the second round of reaction (40 cycles) with ST 3 and ST 4, and not by the nested reaction, as for S. typhi. As shown in the sensitivity test for S. typhi DNA, the single-round reaction is insufficient to detect a small number of organisms in clinical specimens. The specificity of the PCR in clinical practice was confirmed by the results of PCR performed on DNA from blood samples of patients with other acute febrile diseases, which were consistently negative for S. typhi DNA.
Our strategy was to develop the PCR technique with which amplified fragments of flagellin gene of S. typhi in the blood could be directly detected on the gel without the use of Southern blot hybridization. For the practical use of the PCR as a diagnostic test, the gel electrophoresis should be sufficient to detect amplification products without the aid of hybridization methods which take at least 2 days with the use of radiolabeled probes. Because patients with typhoid fever generally have a very low level of bacteremia, the PCR should be sensitive enough to detect 1 to 10 organisms. As shown in a sensitivity test of the PCR performed on mixtures of DNA from mononuclear cells and S. typhi DNA, which could partly simulate the actual blood specimens, the nested PCR was necessary to detect approximately 10 organisms of S. typhi on the gel electrophoresis. The use of mononuclear cells instead of whole blood was to separate the bacteria from erythrocyte debris or serum proteins which could interfere with the detection of S. typhi DNA in the blood.
The ultimate objective of our study was to use the PCR technique to detect S. typhi DNA in the blood of patients with typhoid fever. Using a DNA derived from isolated Salmonella strains, Frankel et al. amplified flagellin gene sequences specifically from S. typhi (4), but there have been no reports of a successful detection of S. typhi DNA in the clinical specimens by use of PCR. In our study, the PCR performed on DNA from the blood specimens successfully detected S. typhi DNA in 11 of 12 specimens on the gel, and Southern blot hybridization confirmed the gel results. Failure to detect S. typhi DNA in one case of actual typhoid fever (Fig. 3, lane 6 ) might be due to partial clotting of the stored blood sample which would result in a significant loss of extractable DNA from mononuclear cells. The PCR could detect S. typhi DNA in the normally prepared blood specimens.
The practical value of PCR in the clinical specimens is the detection of S. typhi DNA in the blood specimens from patients with suspected clinical findings but with negative cultures. The low level of bacteremia in typhoid patients can cause negative blood culture, particularly if the patient has been treated with antibiotics before cultures. This situation is relatively common in endemic areas such as Korea or Southeast Asia. Depending on the conventional diagnostic methods, these culture-negative cases cannot be confirmatively diagnosed as typhoid fever. Pretreatment with antibiotics also can cause some modifications of clinical features of typhoid fever and may lead to unnecessary workup for the cause of fever as well as improper treatment. In our study, PCR performed on DNA from the blood of four patients in this setting successfully detected amplification products in all blood specimens. On the basis of the results of the PCR, these patients were treated with ciprofloxacin (500 mg twice a day, orally) for 14 days with an excellent outcome. We minimized the possibility of false-positive results of the PCR by meticulous handling of the materials and the simultaneous application of multiple negative controls. This finding suggests that the PCR can reinforce the clinical diagnosis of typhoid fever in culture-negative cases and can avoid other unnecessary workup.
By using two pairs of primers evaluated in this study, amplification of the flagellin gene of S. typhi identified the presence of the organism in the blood of patients. The nested PCR resulted in amplified fragments that were visible after agarose gel electrophoresis, which can preclude the use of Southern blot hybridization. The whole procedure to identify S. typhi DNA in the blood by agarose gel electrophoresis took only 16 h, demonstrating the PCR to be a simple, specific, and rapid method for the early diagnosis of typhoid fever.
